Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
4,096 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Thursday, Nov 12 · in 76 days · 100 companies | |||||
| ONDS | Ondas Inc. | Drones and uav | $4.70B | +4.58% | |
| EQPT | EquipmentShare.com Inc. | Specialty finance | $4.58B | −6.62% | |
| MANE | Veradermics, Incorporated | Rare disease | $4.29B | −7.84% | |
| PPTA.TO | Perpetua Resources Corp. | Gold mining | $3.23B | +45.61% | |
| PPTA | |||||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| Gold mining |
| $3.22B |
| +48.19% |
| INFQ | Infleqtion, Inc. | Quantum computing | $3.12B | +41.53% |
| ALMS | Alumis Inc. | Neuroscience | $3.06B | −12.62% |
| B72.DE | AtaiBeckley Inc. | Psychedelic therapeutics | $2.79B | +2.38% |
| ATAI | AtaiBeckley Inc. | Psychedelic therapeutics | $2.74B | +2.92% |
| PGEN | Precigen, Inc. | Gene therapy | $2.65B | +34.18% |
| TRVI | Trevi Therapeutics, Inc. | Rare disease | $2.55B | −2.77% |
| NKTR | Nektar Therapeutics | Rare disease | $2.52B | +4.24% |
| STUB | StubHub Holdings, Inc. | Ecommerce marketplaces | $2.51B | −22.95% |
| KOD | Kodiak Sciences Inc. | Vision and ophthalmology | $2.48B | −2.38% |
| ZBIO | Zenas BioPharma, Inc. | Rare disease | $2.15B | +2.32% |
| PIII | P3 Health Partners Inc. | Hospitals and providers | $1.98B | −5.70% |
| SBET | Sharplink, Inc. | Cryptocurrency and digital assets | $1.81B | +29.19% |
| ETON | Eton Pharmaceuticals, Inc. | Rare disease | $1.79B | +34.20% |
| RMIX | Suncrete, Inc. | Cement and aggregates | $1.73B | −2.27% |
| IAU.TO | i-80 Gold Corp. | Gold mining | $1.66B | +43.17% |
| WWW | Wolverine World Wide, Inc. | Apparel and footwear | $1.65B | −3.69% |
| IAUX | i-80 Gold Corp. | Gold mining | $1.63B | +45.74% |
| PBT | Permian Basin Royalty Trust | Oil and gas exploration | $1.57B | +20.71% |
| LBRX | LB Pharmaceuticals Inc | Neuroscience | $1.55B | +37.85% |
| SBH | Sally Beauty Holdings, Inc. | Specialty retail | $1.55B | +7.18% |
| AKTS | Aktis Oncology, Inc. | Oncology | $1.47B | +15.41% |
| ORIC | ORIC Pharmaceuticals, Inc. | Oncology | $1.44B | +16.79% |
| MGTX | MeiraGTx Holdings plc | Gene therapy | $1.43B | +26.23% |
| OMER | Omeros Corporation | Rare disease | $1.40B | +61.52% |
| JBIO | Jade Biosciences, Inc. | Rare disease | $1.39B | +8.27% |
| EPC | Edgewell Personal Care Company | Beauty and personal care | $1.33B | +1.34% |
| TE | T1 Energy Inc. | Solar | $1.33B | +8.67% |
| VOR | Vor Biopharma Inc. | Cell therapy | $1.30B | +18.35% |
| YSS | York Space Systems, Inc. | Space launch and satellites | $1.25B | −48.74% |
| SPH | Suburban Propane Partners, L.P. | Natural gas utilities | $1.18B | −3.78% |
| HZO | MarineMax, Inc. | Specialty retail | $1.15B | +46.87% |
| LMRI | Lumexa Imaging Holdings, Inc. | Hospitals and providers | $1.15B | +9.02% |
| AVTX | Avalo Therapeutics, Inc. | Rare disease | $1.10B | +5.28% |
| AVEX | AEVEX Corp. | Drones and uav | $1.04B | +20.58% |
| CADL | Candel Therapeutics, Inc. | Oncology | $1.02B | +37.19% |
| EVLV | Evolv Technologies Holdings, Inc. | AI applications | $935.33M | −7.14% |
| LWLG | Lightwave Logic, Inc. | Semiconductor design | $898.80M | +1.22% |
| BZH | Beazer Homes USA, Inc. | Homebuilders | $884.16M | −0.78% |
| CDNL | Cardinal Infrastructure Group Inc. | Construction and engineering | $861.30M | −31.42% |
| BTGO | BitGo Holdings, Inc. | Cryptocurrency and digital assets | $825.17M | +41.25% |
| DC | Dakota Gold Corp. | Gold mining | $818.46M | +29.79% |
| AURA | Aura Biosciences, Inc. | Oncology | $801.64M | +9.65% |
| UU8.F | Neurogene Inc. | Gene therapy | $795.50M | +21.17% |
| STTK | Shattuck Labs, Inc. | Rare disease | $792.87M | +15.84% |
| SATL | Satellogic Inc. | Space launch and satellites | $788.69M | +45.33% |
| HIVE | HIVE Digital Technologies Ltd. | Bitcoin mining | $787.18M | +1.06% |
| WYFI | WhiteFiber, Inc. | AI datacenter infrastructure | $776.96M | −14.93% |
| NGNE | Neurogene Inc. | Gene therapy | $768.64M | +15.62% |
| MNPR | Monopar Therapeutics Inc. | Oncology | $763.31M | +4.24% |
| SSYS | Stratasys Ltd. | Industrial automation | $693.69M | −0.38% |
| CTGO.TO | Contango Silver & Gold Inc. | Gold mining | $680.66M | +26.68% |
| EIKN | Eikon Therapeutics, Inc. | Oncology | $679.77M | +26.24% |
| CTGO | Contango Silver & Gold Inc. | Gold mining | $678.85M | +28.64% |
| SGMT | Sagimet Biosciences Inc. | Oncology | $675.04M | +49.38% |
| ENHA | Enhanced Group Inc. | — | $632.13M | −41.88% |
| ASPI | ASP Isotopes Inc. | Nuclear power | $604.81M | +4.50% |
| MPLT | MapLight Therapeutics, Inc. | Neuroscience | $596.42M | +4.47% |
| SWMR | Swarmer, Inc | Drones and uav | $590.47M | −3.26% |
| NPB | Northpointe Bancshares, Inc. | Regional banks | $584.09M | −2.37% |
| 0KBU.L | Omeros Corporation | Rare disease | $575.28M | −4.75% |
| ZURA | Zura Bio Limited | Rare disease | $574.02M | +8.12% |
| BTBT | Bit Digital, Inc. | Cryptocurrency and digital assets | $562.59M | +20.00% |
| SPIR | Spire Global, Inc. | Space launch and satellites | $550.03M | +19.09% |
| NUAI | New Era Energy & Digital, Inc. | AI datacenter infrastructure | $526.40M | +12.40% |
| RLMD | Relmada Therapeutics, Inc. | Oncology | $485.35M | −13.00% |
| FRX.TO | Fennec Pharmaceuticals Inc. | Oncology | $429.52M | +21.86% |
| FENC | Fennec Pharmaceuticals Inc. | Oncology | $426.77M | +22.43% |
| BOC | Boston Omaha Corporation | Telecom infrastructure | $423.58M | −2.85% |
| DGXX | Digi Power X Inc. | AI datacenter infrastructure | $410.66M | +6.27% |
| LWAY | Lifeway Foods, Inc. | Packaged foods | $399.88M | −13.97% |
| IPSC | Century Therapeutics, Inc. | Cell therapy | $392.93M | +4.39% |
| AIRJ | AirJoule Technologies Corporation | Water utilities and treatment | $354.27M | +11.55% |
| SABS | SAB Biotherapeutics, Inc. | Diabetes care | $353.03M | +12.46% |
| CDZI | Cadiz Inc. | Water utilities and treatment | $350.56M | +30.84% |
| MRLN | Merlin, Inc. | Autonomous driving software | $338.58M | −6.74% |
| FOSL | Fossil Group, Inc. | Apparel and footwear | $322.89M | +22.07% |
| DUOT | Duos Technologies Group, Inc. | AI datacenter infrastructure | $321.65M | +28.53% |
| MLP | Maui Land & Pineapple Company, Inc. | Real estate services | $317.55M | −7.36% |
| FATE | Fate Therapeutics, Inc. Common Stock | Cell therapy | $305.54M | +10.78% |
| TLSI | TriSalus Life Sciences, Inc. | Medical devices | $303.56M | +13.86% |
| NXDT | NexPoint Diversified Real Estate Trust | Specialty reit | $297.92M | +3.37% |
| KLC | KinderCare Learning Companies, Inc. | Edtech | $295.11M | −52.84% |
| TTRX | Turn Therapeutics Inc. | Rare disease | $292.44M | +25.06% |
| CV | CapsoVision, Inc. | Medical devices | $291.27M | −12.08% |
| SLNH | Soluna Holdings, Inc. | Bitcoin mining | $283.73M | −4.92% |
| GLSI | Greenwich LifeSciences, Inc. | Oncology | $267.58M | +35.54% |
| MGNX | MacroGenics, Inc. Common Stock | Oncology | $257.35M | +4.94% |
| LIEN | Chicago Atlantic BDC, Inc. | Specialty finance | $231.63M | +7.98% |
| IMUX | Immunic, Inc. | Neuroscience | $225.00M | +23.61% |
| VUZI | Vuzix Corporation Common Stock | AR VR mixed reality | $224.54M | +18.22% |
| ORMP | Oramed Pharmaceuticals Inc. | Diabetes care | $218.55M | +28.06% |
| MDV | Modiv Industrial, Inc. | Industrial reit | $215.10M | +3.86% |
| KEI.TO | Kolibri Global Energy Inc. | Oil and gas exploration | $205.72M | +15.87% |
| KGEI | Kolibri Global Energy Inc. | Oil and gas exploration | $205.53M | +17.90% |
| ACOG | Alpha Cognition Inc. | Neuroscience | $204.93M | +11.89% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.